Long-term quality of life after radical prostatectomy: 8-Year longitudinal study in Japan

International Journal of Urology

Volumn 21, Issue 12, 2014, Pages 1220-1226

  Namiki, Shunichi ^a   Kaiho, Yasuhiro ^a   Mitsuzuka, Koji ^a   Saito, Hideo ^a   Yamada, Shigeyuki ^a   Nakagawa, Haruo ^a   Ito, Akihiro ^a   Arai, Yoichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Prostate cancer; Quality of life; Questionnaires; Radical prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; FOLLOW UP; GENITAL SYSTEM DISEASE ASSESSMENT; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; JAPAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER INDEX; PROSTATECTOMY; QUALITY OF LIFE; SALVAGE THERAPY; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SHORT FORM 36; URINE INCONTINENCE; HEALTH STATUS; POSTOPERATIVE PERIOD; PROSTATIC NEOPLASMS; PSYCHOLOGY; QUESTIONNAIRE; TIME; TREATMENT OUTCOME;

AGED; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; JAPAN; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84925271465     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12586     Document Type: Article

References (30)

1. Bill-Axelson A, Holmberg L, Ruutu M etal. Radical prostatectomy versus watchful waiting in early prostate cancer. N. Engl. J. Med. 2011; 364: 1708-1717.
2. Mettlin CJ, Murphy GP, Babaian RJ etal. Observations on the early detection of prostate cancer from the American Cancer Society National Prostate Cancer Detection Project. Cancer 1997; 80: 1814-1817.
3. Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J. Urol. 2001; 166: 947-952.
4. Namiki S, Ishidoya S, Ito A etal. Quality of life after radical prostatectomy in Japanese men: a 5-year follow up study. Int. J. Urol. 2009; 16: 75-81.
5. Huang GJ, Sadetsky N, Penson DF. Health related quality of life for men treated for localized prostate cancer with long-term followup. J. Urol. 2010; 183: 2206-2212.
6. Litwin MS, Gore JL, Kwan L etal. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007; 109: 2239-2247.
7. Miller DC, Sanda MG, Dunn RL etal. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J. Clin. Oncol. 2005; 23: 2772-2780.
8. Walz J, Gallina A, Saad F etal. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J. Clin. Oncol. 2007; 25: 3576-3581.
9. Kuwata Y, Muneuchi G, Igawa H, Tsukuda F, Inui M, Kakehi Y. Dissociation of sexual function and sexual bother following autologous sural nerve grafting during radical prostatectomy. Int. J. Urol. 2007; 14: 510-514.
10. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993; 2: 217-227.
11. Suzukamo Y, Fukuhara S, Green J, Kosinski M, Gandek B, Ware JE. Validation testing of a three-component model of Short Form-36 scores. J. Clin. Epidemiol. 2011; 64: 301-308.
12. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med. Care 1998; 36: 1002-1012.
13. Barry MJ, Fowler FJ, O'Leary MP etal. The American Urological Association symptom index for benign prostatic hyperplasia. J. Urol. 1992; 148: 1549-1577.
14. Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B. Psychometricand clinical tests of validity of the Japanese SF-36 Health Survey. J. Clin. Epidemiol. 1998; 51: 1045-1053.
15. Talcott JA, Manola J, Clark JA etal. Time course and predictors of symptoms after primary prostate cancer therapy. J. Clin. Oncol. 2003; 21: 3979-3986.
16. Litwin MS, Melmed GY, Nakazon T. Life after radical prostatectomy: a longitudinal study. J. Urol. 2001; 166: 587-592.
17. Resnick MJ, Koyama T, Fan KH etal. Long-term functional outcomes after treatment for localized prostate cancer. N. Engl. J. Med. 2013; 368: 436-445.
18. Prabhu V, Sivarajan G, Taksler GB, Laze J, Lepor H. Long-term Continence Outcomes in Men Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer. Eur. Urol. 2014; 65: 58-65.
19. Naselli A, Simone G, Papalia R etal. Late-onset incontinence in a cohort of radical prostatectomy patients. Int. J. Urol. 2011; 18: 76-79.
20. Johansson E, Steineck G, Holmberg L etal. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol. 2011; 12: 891-899.
21. Namiki S, Saito S, Nakagawa H, Sanada T, Yamada A, Arai Y. Impact of unilateral sural nerve graft on recovery of potency and continence following radical prostatectomy: 3-year longitudinal study. J. Urol. 2007; 178: 212-216.
22. Davis JW, Chang DW, Chevray P etal. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer. Eur. Urol. 2009; 55: 1135-1143.
23. Penson DF, Latini DM, Lubeck DP, Wallace K, Henning JM, Lue T. Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes? Results from the ExCEED data base. J. Urol. 2003; 169: 1458-1461.
24. Khemees TA, Novak R, Abaza R. Risk and prevention of acute urinary retention after robotic prostatectomy. J. Urol. 2013; 189: 1432-1436.
25. Lepor H, Kaci L. The impact of open radical retropubic prostatectomy on continence and lower urinary tract symptoms: a prospective assessment using validated self-administered outcome instruments. J. Urol. 2004; 171: 1216-1219.
26. Namiki S, Ishidoya S, Saito S etal. Natural history of voiding function after radical retropubic prostatectomy. Urology 2006; 68: 142-147.
27. Namiki S, Saito S, Tochigi T, Ioritani N, Terai A, Arai Y. Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy. Int. J. Urol. 2007; 14: 186-191.
28. Wei JT, Dunn RL, Sandler HM etal. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J. Clin. Oncol. 2002; 20: 557-566.
29. Albertsen PC, Hanley JA, Penson DF, Barrows G, Fine J. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort. J. Urol. 2007; 177: 932-938.
30. Montorsi F, Wilson TG, Rosen RC etal. Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur. Urol. 2012; 62: 368-381.